Saturday, July 22, 2017
As the cost of gene sequencing continues to decrease, we have an unprecedented amount of data about our genome that’s helping us understand more about our bodies. This area presents a lot of opportunities for pharmaceutical companies, health insurance, and investors as both tech and biology converge. But how much of this is hype and
[ Read More ]The 21st Century Cures Act, (Cures) a bipartisan, comprehensive law, supports the discovery, development, and delivery of new treatments to maintain Americas global status in biomedical innovation.
[ Read More ]ACO & Payer Leadership Summit a premium forum for payer and ACO executives Shorten Your Sales Cycle by initiating new relationships directly with decision makers and develop rapport face-to-face. I found a lot of benefits not only from the sessions’ content but also the one on one meetings.” marcus evans runs a first class operation.
[ Read More ]
